MSCs are widely applied to regenerate heart tissue in myocardial diseases but when grown in standard two-dimensional (2D) cultures exhibit limited potential for cardiac repair and develop fibrogenic features with increasing culture time. MSCs can undergo partial cardiomyogenic differentiation, which improves their cardiac repair capacity. When applied to collagen patches they may improve cardiac tissue regeneration but the mechanisms remain elusive. Here, we investigated the regenerative properties of MSCs grown in a collagen scaffold as a three-dimensional (3D) culture system, and performed functional analysis using an engineered heart tissue (EHT) model. We showed that the expression of cardiomyocyte-specific proteins by MSCs co-cultured ...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
There is growing interest in the use of cardiomyocytes purified from embryonic stem (ES) cells for t...
[[abstract]]©2008 Elsevier - Growing three-dimensional scaffolds that contain more than a few layers...
Abstract Background Tissue engineering scaffold constitutes a new strategy of myocardial repair. Her...
MSCs show promise for cell therapy due to their immune-suppressive and regenerative properties. Cons...
MSCs show promise for cell therapy due to their immune-suppressive and regenerative properties. Cons...
Cardiovascular diseases (CVD) are the leading cause of death in the developed countries. According t...
Cardiovascular diseases (CVD) are the leading cause of death in the developed countries. According t...
Myocardial infarction is the leading cause of morbidity and mortality in developed countries. It cau...
Endogenous adult cardiac regenerative machinery is not capable of replacing the lost cells following...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Myocardial infarction is the leading cause of morbidity and mortality in developed countries. It cau...
Myocardial infarction is the leading cause of morbidity and mortality in developed countries. It cau...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
There is growing interest in the use of cardiomyocytes purified from embryonic stem (ES) cells for t...
[[abstract]]©2008 Elsevier - Growing three-dimensional scaffolds that contain more than a few layers...
Abstract Background Tissue engineering scaffold constitutes a new strategy of myocardial repair. Her...
MSCs show promise for cell therapy due to their immune-suppressive and regenerative properties. Cons...
MSCs show promise for cell therapy due to their immune-suppressive and regenerative properties. Cons...
Cardiovascular diseases (CVD) are the leading cause of death in the developed countries. According t...
Cardiovascular diseases (CVD) are the leading cause of death in the developed countries. According t...
Myocardial infarction is the leading cause of morbidity and mortality in developed countries. It cau...
Endogenous adult cardiac regenerative machinery is not capable of replacing the lost cells following...
Heart disease is the leading cause of death in many developing and industrialized countries. The los...
Myocardial infarction is the leading cause of morbidity and mortality in developed countries. It cau...
Myocardial infarction is the leading cause of morbidity and mortality in developed countries. It cau...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
International audienceABSTRACT: BACKGROUND: Tissue engineering scaffold constitutes a new strategy o...
There is growing interest in the use of cardiomyocytes purified from embryonic stem (ES) cells for t...